Cargando…
Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections
The recent Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak poses a serious threat to public health. Here, we summarize recent advances in identifying human neutralizing monoclonal antibodies (mAbs) against MERS-CoV, describe their mechanisms of action, and analyze their potential fo...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Institut Pasteur. Published by Elsevier Masson SAS
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308519/ https://www.ncbi.nlm.nih.gov/pubmed/25456101 http://dx.doi.org/10.1016/j.micinf.2014.11.008 |